Sibley Memorial Hospital is providing outpatient infusion therapy for patients with COVID-19.

The infusion center administers monoclonal antibody therapies authorized by the U.S. Food and Drug Administration (FDA) under an emergency use authorization (EUA). Referrals from credentialed providers are required. Monoclonal antibody therapy helps prevent hospitalization or worsening of symptoms in certain patients with COVID-19, but it may not be appropriate for everyone.

For Referring Providers - Sibley Memorial Hospital Credentialed Providers

Bebtelovimab is currently being offered at this site. To refer a patient with COVID-19 for treatment, complete the requisition form.

For Evusheld pre-exposure prophylaxis, use this referral form. Please note that supply is extremely limited at this time.

Requests may only come from Sibley credentialed providers. Patients, please call your provider to inquire about monoclonal antibody therapy.

Sibley credentialed providers – send completed forms:

• By secure email to [email protected] (Note: Include [secure] in the subject line of the email to encrypt it to meet HIPAA requirement.)
• By fax to 202-537-0072.

After receiving your form, a pharmacy staff member will contact you/your office regarding approval or denial decisions based on drug availability and inclusion criteria. If the patient is a new Sibley patient, a medical record will be created. Appointments will be made on a first-come, first-served basis to ensure equitable and fair distribution. Once the order is placed, a Sibley staff member will contact the patient to coordinate services as soon as possible.

For more information for Sibley credentialed providers, please call 202-660-6948 to hear a recorded message with details about the referral process.